Genelux Corp Financials
This page shows Genelux Corp (GNLX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Genelux Corp has an operating margin of -415175.0%, meaning the company retains $-415175 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -396200.0% the prior year.
Genelux Corp's revenue grew a modest 0.0% year-over-year to $8K. This slow but positive growth earns a score of 33/100.
Genelux Corp carries a low D/E ratio of 0.65, meaning only $0.65 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.
Genelux Corp's current ratio of 2.43 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.
While Genelux Corp generated -$25.3M in operating cash flow, capex of $1.1M consumed most of it, leaving -$26.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Genelux Corp generates a -278.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -113.7% the prior year.
Genelux Corp passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Genelux Corp generates $0.79 in operating cash flow (-$25.3M OCF vs -$32.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Genelux Corp generated $8K in revenue in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Genelux Corp's EBITDA was -$33.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.8% from the prior year.
Genelux Corp reported -$32.1M in net income in fiscal year 2025. This represents a decrease of 7.6% from the prior year.
Genelux Corp earned $-0.86 per diluted share (EPS) in fiscal year 2025. This represents an increase of 9.5% from the prior year.
Cash & Balance Sheet
Genelux Corp generated -$26.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 22.0% from the prior year.
Genelux Corp held $5.3M in cash against $0 in long-term debt as of fiscal year 2025.
Genelux Corp had 45M shares outstanding in fiscal year 2025. This represents an increase of 29.0% from the prior year.
Margins & Returns
Genelux Corp's operating margin was -415175.0% in fiscal year 2025, reflecting core business profitability. This is down 18975.0 percentage points from the prior year.
Genelux Corp's net profit margin was -401812.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 28450.0 percentage points from the prior year.
Genelux Corp's ROE was -278.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 164.8 percentage points from the prior year.
Capital Allocation
Genelux Corp invested $19.9M in research and development in fiscal year 2025. This represents an increase of 4.5% from the prior year.
Genelux Corp invested $1.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 188.2% from the prior year.
GNLX Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | $8K | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $4.7M-0.4% | $4.8M+1.3% | $4.7M | N/A | $4.1M-8.3% | $4.4M+10.1% | $4.0M | N/A |
| SG&A Expenses | $3.5M+13.8% | $3.0M-2.7% | $3.1M | N/A | $2.9M+16.8% | $2.5M-39.8% | $4.1M | N/A |
| Operating Income | -$8.2M-5.2% | -$7.8M+0.3% | -$7.8M | N/A | -$6.9M-0.7% | -$6.9M+15.1% | -$8.1M | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$8.0M-6.6% | -$7.5M+0.5% | -$7.5M | N/A | -$6.5M+1.7% | -$6.6M+16.2% | -$7.8M | N/A |
| EPS (Diluted) | $-0.21-5.0% | $-0.20+4.8% | $-0.21 | N/A | $-0.19+13.6% | $-0.22+24.1% | $-0.29 | N/A |
GNLX Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.0M-22.5% | $32.2M-17.3% | $39.0M+12.3% | $34.7M-13.8% | $40.3M-10.9% | $45.2M+83.1% | $24.7M-11.5% | $27.9M |
| Current Assets | $21.6M-26.3% | $29.2M-18.7% | $35.9M+13.9% | $31.5M-12.3% | $36.0M+3.1% | $34.9M+64.5% | $21.2M-12.4% | $24.2M |
| Cash & Equivalents | $4.7M-28.3% | $6.5M-59.6% | $16.2M+89.2% | $8.6M+40.4% | $6.1M-22.3% | $7.9M+93.5% | $4.1M-56.9% | $9.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6.4M-23.4% | $8.3M-8.6% | $9.1M+8.3% | $8.4M+17.6% | $7.2M-4.4% | $7.5M-21.7% | $9.6M+13.9% | $8.4M |
| Current Liabilities | $5.1M-26.6% | $7.0M-9.1% | $7.7M+11.4% | $6.9M+24.3% | $5.6M-4.3% | $5.8M-25.7% | $7.8M+19.1% | $6.6M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $18.6M-22.2% | $23.9M-19.9% | $29.8M+13.6% | $26.3M-20.6% | $33.1M-12.2% | $37.7M+149.7% | $15.1M-22.5% | $19.5M |
| Retained Earnings | -$274.3M-3.0% | -$266.3M-2.9% | -$258.9M-3.0% | -$251.4M-3.7% | -$242.4M-2.7% | -$235.9M-2.9% | -$229.4M-3.5% | -$221.5M |
GNLX Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$6.6M+6.9% | -$7.1M-29.9% | -$5.4M-26.3% | -$4.3M+25.2% | -$5.7M+15.8% | -$6.8M-56.7% | -$4.4M+37.0% | -$6.9M |
| Capital Expenditures | $517K+349.6% | $115K+283.3% | $30K-68.8% | $96K+255.6% | $27K-88.2% | $228K+660.0% | $30K-87.7% | $243K |
| Free Cash Flow | -$7.1M+1.1% | -$7.2M-31.3% | -$5.5M-24.3% | -$4.4M+23.8% | -$5.8M+18.1% | -$7.1M-60.9% | -$4.4M+38.7% | -$7.2M |
| Investing Cash Flow | $4.7M+277.9% | -$2.7M-175.6% | $3.5M-47.4% | $6.7M+67.2% | $4.0M+123.3% | -$17.1M-911.6% | -$1.7M+87.9% | -$13.9M |
| Financing Cash Flow | $0-100.0% | $52K-99.5% | $9.6M+10413.2% | $91K | $0-100.0% | $27.7M+3930.1% | $688K+71.6% | $401K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GNLX Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | -101437.5% | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | -98125.0% | N/A |
| Return on Equity | -42.8%-11.6pp | -31.2%-6.1pp | -25.1% | N/A | -19.5%-2.1pp | -17.5%+34.6pp | -52.0% | N/A |
| Return on Assets | -31.8%-8.7pp | -23.1%-3.9pp | -19.2% | N/A | -16.1%-1.5pp | -14.6%+17.3pp | -31.8% | N/A |
| Current Ratio | 4.20+0.0 | 4.18-0.5 | 4.67+0.1 | 4.57-1.9 | 6.47+0.5 | 6.01+3.3 | 2.72-1.0 | 3.69 |
| Debt-to-Equity | 0.340.0 | 0.35+0.0 | 0.31-0.0 | 0.32+0.1 | 0.22+0.0 | 0.20-0.4 | 0.64+0.2 | 0.43 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | -54800.0% | N/A |
Similar Companies
Frequently Asked Questions
What is Genelux Corp's annual revenue?
Genelux Corp (GNLX) reported $8K in total revenue for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Genelux Corp's revenue growing?
Genelux Corp (GNLX) revenue grew by 0% year-over-year, from $8K to $8K in fiscal year 2025.
Is Genelux Corp profitable?
No, Genelux Corp (GNLX) reported a net income of -$32.1M in fiscal year 2025, with a net profit margin of -401812.5%.
What is Genelux Corp's EBITDA?
Genelux Corp (GNLX) had EBITDA of -$33.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Genelux Corp's operating margin?
Genelux Corp (GNLX) had an operating margin of -415175.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Genelux Corp's net profit margin?
Genelux Corp (GNLX) had a net profit margin of -401812.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Genelux Corp's return on equity (ROE)?
Genelux Corp (GNLX) has a return on equity of -278.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Genelux Corp's free cash flow?
Genelux Corp (GNLX) generated -$26.4M in free cash flow during fiscal year 2025. This represents a -22.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Genelux Corp's operating cash flow?
Genelux Corp (GNLX) generated -$25.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Genelux Corp's total assets?
Genelux Corp (GNLX) had $19.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Genelux Corp's capital expenditures?
Genelux Corp (GNLX) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Genelux Corp spend on research and development?
Genelux Corp (GNLX) invested $19.9M in research and development during fiscal year 2025.
What is Genelux Corp's current ratio?
Genelux Corp (GNLX) had a current ratio of 2.43 as of fiscal year 2025, which is generally considered healthy.
What is Genelux Corp's debt-to-equity ratio?
Genelux Corp (GNLX) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Genelux Corp's return on assets (ROA)?
Genelux Corp (GNLX) had a return on assets of -168.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Genelux Corp's cash runway?
Based on fiscal year 2025 data, Genelux Corp (GNLX) had $5.3M in cash against an annual operating cash burn of $25.3M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Genelux Corp's Piotroski F-Score?
Genelux Corp (GNLX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Genelux Corp's earnings high quality?
Genelux Corp (GNLX) has an earnings quality ratio of 0.79x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Genelux Corp?
Genelux Corp (GNLX) scores 28 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.